Survival benefit from bevacizumab in newly diagnosed glioblastoma (GBM) according to transcriptional subclasses Meeting Abstract


Authors: Huse, J. T.; Beal, K.; Zhang, J.; Kastenhuber, E. R.; Kaley, T. J.; Abrey, L. E.; Gutin, P. H.; Brennan, C. W.; Omuro, A. M. P.
Abstract Title: Survival benefit from bevacizumab in newly diagnosed glioblastoma (GBM) according to transcriptional subclasses
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Language: English
ACCESSION: WOS:000335419600718
PROVIDER: wos
Notes: Meeting Abstract: 2057 -- Source: Wos
MSK Authors
  1. Philip H Gutin
    152 Gutin
  2. Cameron Brennan
    155 Brennan
  3. Antonio Marcilio Padula Omuro
    177 Omuro
  4. Kathryn Beal
    157 Beal
  5. Thomas Kaley
    89 Kaley
  6. Lauren E Abrey
    272 Abrey
  7. Jason T Huse
    127 Huse
  8. Jianan Zhang
    7 Zhang